M. G. Sevag

1.8k total citations
31 papers, 279 citations indexed

About

M. G. Sevag is a scholar working on Molecular Biology, Genetics and Pollution. According to data from OpenAlex, M. G. Sevag has authored 31 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Genetics and 5 papers in Pollution. Recurrent topics in M. G. Sevag's work include Bacterial Genetics and Biotechnology (6 papers), Bacteriophages and microbial interactions (4 papers) and Pharmaceutical and Antibiotic Environmental Impacts (4 papers). M. G. Sevag is often cited by papers focused on Bacterial Genetics and Biotechnology (6 papers), Bacteriophages and microbial interactions (4 papers) and Pharmaceutical and Antibiotic Environmental Impacts (4 papers). M. G. Sevag collaborates with scholars based in United States. M. G. Sevag's co-authors include Hillel S. Levinson, Masanosuke Yoshikawa, Martin Forbes, W. T. Drabble, Gerhard Haas, Takeshi Yokota, Richard C. Stewart, K. Ishii, Akira Yoshida and Irving J. Slotnick and has published in prestigious journals such as Nature, The Journal of Immunology and Cancer.

In The Last Decade

M. G. Sevag

31 papers receiving 243 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. G. Sevag United States 10 132 29 28 27 27 31 279
D.R.D. Shaw United States 8 148 1.1× 20 0.7× 25 0.9× 50 1.9× 18 0.7× 12 323
L. G. Sellers United States 9 167 1.3× 16 0.6× 13 0.5× 11 0.4× 35 1.3× 14 311
Gloria A. Heym United States 11 267 2.0× 10 0.3× 26 0.9× 38 1.4× 49 1.8× 18 433
Elizabeth Bugie United States 3 112 0.8× 71 2.4× 22 0.8× 29 1.1× 12 0.4× 3 249
Elizabeth H. Thiele United States 9 84 0.6× 12 0.4× 83 3.0× 26 1.0× 10 0.4× 18 281
Josef Primosigh Germany 4 179 1.4× 16 0.6× 32 1.1× 72 2.7× 45 1.7× 5 309
Stephen M. Hammond United Kingdom 6 166 1.3× 26 0.9× 16 0.6× 24 0.9× 15 0.6× 8 310
Gerda Groen Netherlands 13 223 1.7× 18 0.6× 9 0.3× 15 0.6× 23 0.9× 15 344
Norman Strauss United States 11 231 1.8× 15 0.5× 47 1.7× 64 2.4× 8 0.3× 17 397
P. G. de Haan Netherlands 12 331 2.5× 12 0.4× 14 0.5× 72 2.7× 29 1.1× 24 441

Countries citing papers authored by M. G. Sevag

Since Specialization
Citations

This map shows the geographic impact of M. G. Sevag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. G. Sevag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. G. Sevag more than expected).

Fields of papers citing papers by M. G. Sevag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. G. Sevag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. G. Sevag. The network helps show where M. G. Sevag may publish in the future.

Co-authorship network of co-authors of M. G. Sevag

This figure shows the co-authorship network connecting the top 25 collaborators of M. G. Sevag. A scholar is included among the top collaborators of M. G. Sevag based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. G. Sevag. M. G. Sevag is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yoshikawa, Masanosuke & M. G. Sevag. (1967). Sensitivity of Escherichia coli to Atabrine Conferred by R Factor and Its Potential Clinical Significance. Journal of Bacteriology. 93(1). 245–253. 24 indexed citations
2.
Sevag, M. G., et al.. (1964). Evolution and Prevention of Drug-Resistance. Nature. 203(4952). 1323–1326. 20 indexed citations
3.
Sevag, M. G. & W. T. Drabble. (1962). Prevention of the emergence of drug-resistant bacteria by polyamines. Biochemical and Biophysical Research Communications. 8(6). 446–452. 12 indexed citations
4.
Sevag, M. G. & Takeshi Yokota. (1960). Evolution of the phenomenon of drug-resistance III. The origin of the development of resistance to sulphathiazole in Escherichia coli and Staphylococcus aureus. Proceedings of the Royal Society of London. Series B, Biological sciences. 153(951). 220–233. 4 indexed citations
5.
Sevag, M. G. & Takeshi Yokota. (1960). Evolution of the phenomenon of drug-resistance. II. Studies of the extracellular and intracellular derivatives of folic acid in relation to resistance to sulphathiazole and growth factor requirements. Proceedings of the Royal Society of London. Series B, Biological sciences. 153(951). 205–219. 5 indexed citations
6.
Sevag, M. G. & K. Ishii. (1958). Drug-induced reversible and irreversible enzyme alterations underlying drug-resistance. Proceedings of the Royal Society of London. Series B, Biological sciences. 149(934). 63–81. 5 indexed citations
7.
Yoshida, Akira & M. G. Sevag. (1958). Effect of streptomycin on phosphate and nucleic acid metabolism of Escherichia coli. Archives of Biochemistry and Biophysics. 77(1). 31–40. 2 indexed citations
8.
Sevag, M. G.. (1957). Induzierter Funktionswandel von Proteinen in Biologie und Medizin. Angewandte Chemie. 69(11). 376–388. 1 indexed citations
9.
Ishii, K. & M. G. Sevag. (1956). Inhibition by cycloserine of the synthesis of 5-amino-4-imidazolecarboxamide by Escherichia coli.. PubMed. 6(8). 500–3. 1 indexed citations
10.
Slotnick, Irving J. & M. G. Sevag. (1955). An investigation of the natural occurrence of 4-amino-5-imidazolecarboxamide in several strains of Escherichia coli. Archives of Biochemistry and Biophysics. 57(2). 491–495. 1 indexed citations
11.
Sevag, M. G., et al.. (1955). MECHANISM OF THE DEVELOPMENT OF RESISTANCE TO STREPTOMYCIN II. Journal of Bacteriology. 69(2). 184–187. 3 indexed citations
12.
Sevag, M. G., et al.. (1954). Phosphatase-antiphosphatase reaction; competition between the specific substrate and antiphosphatase for phosphatase.. PubMed. 72(1). 1–11. 12 indexed citations
13.
Levinson, Hillel S. & M. G. Sevag. (1954). MANGANESE AND THE PROTEOLYTIC ACTIVITY OF SPORE EXTRACTS OF BACILLUS MEGATERIUM IN RELATION TO GERMINATION. Journal of Bacteriology. 67(5). 615–616. 13 indexed citations
14.
Levinson, Hillel S. & M. G. Sevag. (1953). STIMULATION OF GERMINATION AND RESPIRATION OF THE SPORES OF BACILLUS MEGATHERIUM BY MANGANESE AND MONOVALENT ANIONS. The Journal of General Physiology. 36(5). 617–629. 57 indexed citations
15.
Haas, Gerhard & M. G. Sevag. (1953). Critical role of amino acids on the sensitivity and development of resistance to polymyxin B. Archives of Biochemistry and Biophysics. 43(1). 11–24. 9 indexed citations
16.
Sevag, M. G., et al.. (1952). MECHANISM OF THE DEVELOPMENT OF RESISTANCE TO STREPTOMYCIN I. Journal of Bacteriology. 63(2). 243–251. 14 indexed citations
17.
Sevag, M. G. & Richard C. Stewart. (1952). 4-Amino-5-imidazolecarboxamide. The relation of its metabolism to citric acid cycle. Archives of Biochemistry and Biophysics. 41(1). 14–20. 2 indexed citations
18.
Forbes, Martin & M. G. Sevag. (1951). Action of Amino Acids on Bacterial Dehydrogenases and Glycolysis. Experimental Biology and Medicine. 77(3). 565–569. 5 indexed citations
19.
Sevag, M. G.. (1951). Immuno-catalysis and related fields of bacteriology and biochemistry. Thomas eBooks. 1 indexed citations
20.
Forbes, Martin & M. G. Sevag. (1951). Inhibition by glucose of the synthesis of proline from glutamic acid. Archives of Biochemistry and Biophysics. 31(3). 406–415. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026